Pharmacokinetics of HLD200 in Children and Adolescents With ADHD
Clinical trial NCT01907360 · COMPLETED
Trial details
- NCT number
- NCT01907360
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2013-10-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.